β-Galactosidase-Cleavable Polymeric Senotherapeutics for Protein-Binding Photodynamic Senolysis.
Abstract
Selective elimination of senescent cells (SnCs) through senolytic strategies can counteract the progression of age-related dysfunction, but achieving precise, broad-spectrum, and controllable senolysis remains challenging. Here, we report PG@FBC, a polymeric senotherapeutic that exploits senescence-associated β-galactosidase (SA-β-gal) to trigger supramolecular disassembly and controlled photosensitizer release, enabling photodynamic senolysis with real-time imaging. Briefly, PG@FBC is composed of an amphiphilic block copolymer, POEGMA-
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper presents a novel polymeric senotherapeutic that utilizes β-galactosidase for targeted elimination of senescent cells. This research is relevant as it addresses a root cause of aging by focusing on the selective removal of senescent cells, which are implicated in age-related dysfunction.
Author of this paper? Send a correction.